drugset / Trial / NCT01219465

Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus

NCT01219465

Phase 1/2 Unknown 50 enrolled Qingdao University
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether umbilical cord Mesenchymal Stem Cells of treatment for initial type 1 diabetes is safe and effective.

Timeline

Start
2010-09
Primary completion
2012-09
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 2e+07 cells Intravenous